Acute phosphate nephropathy following colonoscopy preparation

American Journal of the Medical Sciences

Volumn 334, Issue 3, 2007, Pages 151-154

  Carl, Daniel E ^a   Sica, Domenic A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; ATORVASTATIN; HYDROCHLOROTHIAZIDE; LAXATIVE; METOPROLOL; PHOSPHATE; THYROXINE; TOLTERODINE; UNCLASSIFIED DRUG; VISICOL;

ACUTE DISEASE; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DRUG MECHANISM; FEMALE; HEMODYNAMICS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; PHYSICAL EXAMINATION; TABLET FORMULATION; ULTRASOUND;

ACUTE DISEASE; BIOPSY; CATHARTICS; COLONOSCOPY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MIDDLE AGED; PHOSPHATES; TREATMENT OUTCOME;

EID: 34548680965     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318156c529     Document Type: Article

References (23)

1. Smith RA, Cokkinides V, von Eschenbach AC, et al. American cancer society guidelines for the early detection of cancer. CA Cancer J Clin 2002;52:8-22.
2. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: A summary of the evidence for the U.S. preventive services task force. Ann Intern Med 2002;136:765-6.
3. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations of the american college of gastroenterology. american college of gastroenterology. Am J Gastroenterol 2000;95:868-77.
4. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: A consensus update by the US multi-society task force on colorectal cancer and the american cancer society. CA Cancer J Clin 2006;56:143-59; quiz 184-5.
5. Faigel DO, Eisen GM. Preparation of patients for GI endoscopy. Gastrointest Endosc 2003;57:446-50.
6. Kastenberg D, Chasen R, Choudhary C, et al. Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: Two identically designed, randomized, controlled, parallel group, multicenter phase III trials. Gastrointest Endosc 2001;54:705-13.
7. Khashab M, Rex DK. Efficacy and tolerability of a new formulation of sodium phosphate tablets (INKP-101), and a reduced sodium phosphate dose, in colon cleansing: A single-center open-label pilot trial. Aliment Pharmacol Ther 2005; 21:465-68.
8. Cohen SM, Wexner SD, Binderow SR, et al. Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum 1994;37:689-96.
9. Curran MP, Plosker GL. Oral sodium phosphate solution: A review of its use as a colorectal cleanser. Drugs 2004;64:1697-714.
10. Schiller LR. Clinical pharmacology and use of laxatives and lavage solutions. J Clin Gastroenterol 1999;28:11-18.
11. Rex DK, Schwartz H, Goldstein M, et al. Safety and colon-cleansing efficacy of a new residue-free formulation of sodium phosphate tablets. Am J Gastroenterol 2006;101:2594-604.
12. Ainslie PN, Campbell IT, Frayn KN, et al. Energy balance, metabolism, hydration, and performance during strenuous hill walking: The effect of age. J Appl Physiol 2002;93:714-23.
13. Miescher E, Fortney SM. Responses to dehydration and rehydration during heat exposure in young and older men. Am J Physiol 1989;257:R1050-6.
14. Desmeules S, Bergeron MJ, Isenring P. Acute phosphate nephropathy and renal failure. N Engl J Med 2003;349:1006-7.
15. Markowitz GS, Nasr SH, Klein P, et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 2004;35:675-84.
16. Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: An underrecognized cause of chronic renal failure. J Am Soc Nephrol 2005;16:3389-96.
17. Markowitz GS, Whelan J, D'Agati VD. Renal failure following bowel cleansing with a sodium phosphate purgative. Nephrol Dial Transplant 2005;20:850-51.
18. Gonlusen G, Akgun H, Ertan A, Olivero J, Truong LD. Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: Clinical patterns and renal biopsy findings. Arch Pathol Lab Med 2006;130:101-6.
19. Fine A, Patterson J. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: Two cases and a review of the literature. Am J Kidney Dis 1997;29:103-5.
20. Vukasin P, Weston LA, Beart RW. Oral fleet phospho-soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult: Report of a case. Dis Colon Rectum 1997;40:497-9.
21. Gumurdulu Y, Serin E, Ozer B, Gokcel A, Boyacioglu S. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol 2004;19:68-72.
22. Tan HL, Liew QY, Loo S, Hawkins R. Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia 2002;57:478-83.
23. Fleet. Letter to U. S. Healthcare Professionals 2005. Available at: http://www.phospho-soda.com/professionals/. Accessed August 2, 2007.